To test if topical treatment with FFA could ameliorate the skin disease associated with KID syndrome, we treated Cx26-G45E transgenic mice with topically applied FFA using commercially available Mobilisin cream (Fig. 4). This evidence concerns the gene GJB2 and KID syndrome.